Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome
Schizophrenia is a severe psychiatric disorder whose neurodevelopmental pathogenesis includes a prodromal phase before its diagnostically decisive—namely psychotic—symptoms are present. This prodrome is characterized by cognitive and affective deficits, and it may constitute a critical time period f...
Main Authors: | Lukas Marius Bühner, Sampath K. T. Kapanaiah, Dennis Kätzel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnbeh.2022.1002223/full |
Similar Items
-
N-acetylcysteine as an adjunct treatment of schizophrenia
by: R. Mota Freitas, et al.
Published: (2021-04-01) -
Animal Models of Relevance to the Schizophrenia Prodrome
by: Alice Petty, et al.
Published: (2023-01-01) -
Prodromal phase and first episode psychosis in schizophrenia: early signs and diagnosis
by: A.-G. Buciuc, et al.
Published: (2022-06-01) -
Motor Symptoms as a Prodrome to Schizophrenia
by: Adam Schindzielorz, et al.
Published: (2022-01-01) -
PRODROMAL PHASE IN THE DEVELOPMENT OF EARLY ONSET SCHIZOPHRENIC PSYCHOSIS - CASE REPORT
by: Jelena Kostić, et al.
Published: (2012-06-01)